v3.23.3
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2020 $ 6 $ 49,517,908 $ (55,958,716) $ (217,625) $ (6,658,427)
Balance, shares at Dec. 31, 2020 65,703        
Exercise of stock options 262,862 262,862
Exercise of stock options, shares 1,186        
Settlement of convertible notes in business combination $ 1 5,696,702 5,696,703
Settlement of convertible notes in business combination, shares 5,658        
Conversion of convertible notes 2,247,615 2,247,615
Conversion of convertible notes, shares 1,614        
Issuance of common stock for business combination, net of transaction costs $ 3 7,695,261 7,695,264
Issuance of common stock for business combination, net of transaction costs, shares 28,517        
Stock-based compensation 121,764 121,764
Issuance of warrants 11,565,472 11,565,472
Warrant modification 56,590 56,590
Deemed dividend related to warrants down round provision 803,140 (803,140)
Net loss (29,083,711) (62,190) (29,145,901)
Balance at Dec. 31, 2021 $ 10 77,967,314 (85,845,567) (279,815) (8,158,058)
Balance, shares at Dec. 31, 2021 102,678        
Stock-based compensation 2,543,388 2,543,388
Deemed dividend related to warrants down round provision 881,598 (881,598)
Net loss (18,681,990) (47,619) (18,729,609)
Consultant Compensation 54,250 54,250
Consultant compensation, shares 208        
Settlement of restricted stock units
Settlement of restricted stock units, shares 2,904        
Conversion of convertible notes $ 8 17,868,089 17,868,097
Convertible Notes, shares 78,155        
Balance at Sep. 30, 2022 $ 18 99,314,639 (105,409,155) (327,434) (6,421,932)
Balance, shares at Sep. 30, 2022 183,945        
Balance at Dec. 31, 2021 $ 10 77,967,314 (85,845,567) (279,815) $ (8,158,058)
Balance, shares at Dec. 31, 2021 102,678        
Exercise of stock options, shares        
Conversion of convertible notes $ 18 21,485,886 $ 21,485,904
Conversion of convertible notes, shares 181,999        
Stock-based compensation 2,760,074 2,760,074
Deemed dividend related to warrants down round provision 913,204 (913,204)
Net loss (24,172,292) (35,393) (24,207,685)
Consultant Compensation 54,250 54,250
Consultant compensation, shares 208        
Settlement of restricted stock units
Settlement of restricted stock units, shares 3,278        
Settlement of payable to related parties $ 1 191,617 191,618
Settlement of related party payable, Share 3,838        
Capital contribution from related parties 608,382 608,382
Public offerings, net $ 24 3,783,216 3,783,240
Public offering, net, shares 241,666        
Transaction costs associated with public offerings (547,377) (547,377)
Reverse split fractional shares
Reverse split fractional shares, shares 823        
Stock Issued During Period, Shares, Reverse Stock Splits (823)        
Balance at Dec. 31, 2022 $ 53 107,216,566 (110,931,063) (315,208) (4,029,652)
Balance, shares at Dec. 31, 2022 534,490        
Balance at Jun. 30, 2022 $ 14 95,019,893 (95,511,543) (305,942) (797,578)
Balance, shares at Jun. 30, 2022 148,037        
Stock-based compensation 157,148 157,148
Deemed dividend related to warrants down round provision 63,539 (63,539)
Net loss (9,834,073) (21,492) (9,855,565)
Settlement of restricted stock units
Settlement of restricted stock units, shares 208        
Conversion of convertible notes $ 4 4,074,059 4,074,063
Convertible Notes, shares 35,700        
Balance at Sep. 30, 2022 $ 18 99,314,639 (105,409,155) (327,434) (6,421,932)
Balance, shares at Sep. 30, 2022 183,945        
Balance at Dec. 31, 2022 $ 53 107,216,566 (110,931,063) (315,208) $ (4,029,652)
Balance, shares at Dec. 31, 2022 534,490        
Exercise of stock options, shares        
Stock-based compensation 250,224   $ 250,224
Deemed dividend related to warrants down round provision 12,038 (12,038)
Net loss (7,109,678) (12,236) (7,121,914)
Settlement of restricted stock units
Settlement of restricted stock units, shares 938        
Public offerings, net $ 139 9,049,865 9,050,004
Public offering, net, shares 1,381,619        
Transaction costs associated with public offerings (447,879) (447,879)
Reverse split fractional shares
Reverse split fractional shares, shares 862        
Conversion of convertible notes $ 41 3,056,851 3,056,892
Convertible Notes, shares 408,580        
Issuance of common stock upon exercise of warrants $ 50 (50)
Balance, shares 494,795        
Settlement of commitment fee $ 4 399,996 400,000
[custom:StockIssuedDuringPeriodSharesCommitmentFee] 44,444        
Stock Issued During Period, Shares, Reverse Stock Splits (862)        
Balance at Sep. 30, 2023 $ 287 119,537,611 (118,052,779) (327,444) 1,157,675
Balance, shares at Sep. 30, 2023 2,864,004        
Balance at Jun. 30, 2023 $ 267 119,481,957 (115,363,208) (326,209) 3,792,807
Balance, shares at Jun. 30, 2023 2,669,792        
Stock-based compensation 55,674 55,674
Net loss (2,689,571) (1,235) (2,690,806)
Settlement of restricted stock units
Settlement of restricted stock units, shares 314        
Issuance of common stock upon exercise of warrants $ 20 (20)
Balance, shares 193,898        
Balance at Sep. 30, 2023 $ 287 $ 119,537,611 $ (118,052,779) $ (327,444) $ 1,157,675
Balance, shares at Sep. 30, 2023 2,864,004